Related Experiment Video
Updated: Mar 16, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism
1Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, China.
Abstract:
Liver kinase B1 (LKB1) is mutationally inactivated in Peutz-Jeghers syndrome and in a variety of cancers including human papillomavirus (HPV)-caused cervical cancer. However, the significance of LKB1 mutations in cervical cancer initiation and progress has not been examined. Herein, we demonstrated that, in mouse embryonic fibroblasts, loss of LKB1 and transduction of HPV16 E6/E7 had an additive effect on constraining cell senescence while promoting cell proliferation and increasing glucose consumption, lactate production and ATP generation. Knockdown of LKB1 increased and ectopic expression of LKB1 decreased glycolysis, anchorage-independent cell growth, and cell migration and invasion in HPV-transformed cells. In the tumorigenesis and lung metastasis model in syngeneic mice, depletion of LKB1 markedly increased tumor metastatic colonies in lungs without affecting subcutaneous tumor growth. We showed that HPV16 E6/E7 enhanced the expression of hexokinase-ll (HK-II) in the glycolytic pathway through elevated c-MYC. Ectopic LKB1 reduced HK-II along with glycolysis. The inverse relationship between HK-II and LKB1 was also observed in normal and HPV-associated cervical lesions. We propose that LKB1 acts as a safeguard against HPV-stimulated aerobic glycolysis and tumor progression. These findings may eventually aid in the development of therapeutic strategy for HPV-associated malignancies by targeting cell metabolism.
Insights
Liver kinase B1 (LKB1) loss promotes cancer growth and metastasis in human papillomavirus (HPV)-associated cancers by increasing glycolysis. Restoring LKB1 can inhibit tumor progression, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Metabolic Pathways
Background:
- Liver kinase B1 (LKB1) is frequently inactivated in various cancers, including human papillomavirus (HPV)-associated cervical cancer.
- The specific role of LKB1 mutations in cervical cancer initiation and progression remains largely unexplored.
Purpose of the Study:
- To investigate the functional significance of LKB1 inactivation in HPV-associated cervical cancer.
- To elucidate the impact of LKB1 on cellular metabolism, proliferation, and metastasis in the context of HPV infection.
Main Methods:
- Utilized mouse embryonic fibroblasts and HPV-transformed cells with LKB1 manipulation (knockdown/ectopic expression).
- Employed tumorigenesis and lung metastasis models in syngeneic mice.
- Analyzed glycolytic pathway enzymes, including hexokinase-II (HK-II), and c-MYC expression.
- Examined LKB1 and HK-II expression in normal and HPV-associated cervical lesions.
Main Results:
- LKB1 loss combined with HPV16 E6/E7 expression promoted cell proliferation and aerobic glycolysis while suppressing senescence.
- LKB1 deficiency enhanced glycolysis, anchorage-independent growth, migration, and invasion in HPV-transformed cells.
- LKB1 depletion significantly increased lung metastasis in vivo, and HPV16 E6/E7 upregulated HK-II via c-MYC, a process reversed by LKB1 reintroduction.
Conclusions:
- LKB1 functions as a tumor suppressor by inhibiting HPV-driven aerobic glycolysis and progression.
- The inverse correlation between LKB1 and HK-II in cervical lesions highlights LKB1's role in metabolic regulation.
- Targeting cellular metabolism, specifically LKB1-mediated pathways, presents a potential therapeutic strategy for HPV-associated malignancies.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Mechanisms of Retrovirus-induced Cancers

